190 related articles for article (PubMed ID: 37148769)
1. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.
Saadh MJ; Kazemi K; Khorramdelazad H; Mousavi MJ; Noroozi N; Masoumi M; Karami J
Int Immunopharmacol; 2023 Jun; 119():110246. PubMed ID: 37148769
[TBL] [Abstract][Full Text] [Related]
2. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy.
Sharabi A; Tsokos GC
Nat Rev Rheumatol; 2020 Feb; 16(2):100-112. PubMed ID: 31949287
[TBL] [Abstract][Full Text] [Related]
3. [Immunometabolism and systemic lupus erythematosus].
Xiao YB; Guo MY; Zuo XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update.
Romo-Tena J; Kaplan MJ
Curr Opin Rheumatol; 2020 Nov; 32(6):562-571. PubMed ID: 32826478
[TBL] [Abstract][Full Text] [Related]
6. Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases.
Chávez MD; Tse HM
Front Immunol; 2021; 12():703972. PubMed ID: 34276700
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
Iwata S; Tanaka Y
Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
[TBL] [Abstract][Full Text] [Related]
8. mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus.
Zhao X; Wang S; Wang S; Xie J; Cui D
Clin Immunol; 2022 Dec; 245():109153. PubMed ID: 36265758
[TBL] [Abstract][Full Text] [Related]
9. T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus.
Shan J; Jin H; Xu Y
Front Immunol; 2020; 11():1027. PubMed ID: 32528480
[TBL] [Abstract][Full Text] [Related]
10. T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative review.
Muñoz-Urbano M; Quintero-González DC; Vasquez G
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):457-470. PubMed ID: 35352607
[TBL] [Abstract][Full Text] [Related]
11. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
12. A cellular overview of immunometabolism in systemic lupus erythematosus.
Psarras A; Clarke A
Oxf Open Immunol; 2023; 4(1):iqad005. PubMed ID: 37554724
[TBL] [Abstract][Full Text] [Related]
13. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
Geginat J; Vasco M; Gerosa M; Tas SW; Pagani M; Grassi F; Flavell RA; Meroni P; Abrignani S
Semin Immunol; 2019 Aug; 44():101330. PubMed ID: 31735515
[TBL] [Abstract][Full Text] [Related]
14. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
[TBL] [Abstract][Full Text] [Related]
15. The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.
Robinson GA; Wilkinson MGL; Wincup C
Front Immunol; 2021; 12():806560. PubMed ID: 35154082
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications.
Yennemadi AS; Keane J; Leisching G
Lupus; 2023 Apr; 32(5):603-611. PubMed ID: 36914582
[TBL] [Abstract][Full Text] [Related]
17. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
Tzeng HT; Chyuan IT
J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
[TBL] [Abstract][Full Text] [Related]
18. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
Blanco LP; Kaplan MJ
PLoS Biol; 2023 Apr; 21(4):e3002084. PubMed ID: 37098006
[TBL] [Abstract][Full Text] [Related]
19. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus.
Takeshima Y; Iwasaki Y; Fujio K; Yamamoto K
Semin Arthritis Rheum; 2019 Jun; 48(6):1142-1145. PubMed ID: 31056210
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus.
Yang J; Yang X; Zou H; Li M
Oxid Med Cell Longev; 2016; 2016():2526174. PubMed ID: 27597882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
